Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Therapeutics|October 15, 2014
Serum ferritin is elevated in advanced non-small cell lung cancer patients and is associated with efficacy of platinum-based chemotherapyHong-Bing Shi, Xiao-Dong Li, Jing-Ting Jiang, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 23, 2010
The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II studyHua Shen, Xiao-Dong Li, Chang-Ping Wu, et al.
International Journal of Clinical and Experimental Medicine|December 3, 2015
Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysisDanxia Zhu, Xiao-Li Xu, Cheng Fang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2012
Review of Chinese clinical trials on CIK cell treatment for malignanciesXiao-Dong Li, Bin Xu, Jun Wu, et al.
World Journal of Surgical Oncology|October 3, 2013
Characteristic analysis of α-fetoprotein-producing gastric carcinoma in ChinaXiao-Dong Li, Chang-Ping Wu, Mei Ji, et al.
Asia-Pacific Journal of Clinical Oncology|September 5, 2018
Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancerXue-Feng Ni, Jun Wu, Mei Ji, et al.
Asia-Pacific Journal of Clinical Oncology|June 4, 2014
Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancerXue-Feng Ni, Ping Wu, Chang-Ping Wu, et al.
Cellular Signalling|July 28, 2021
Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathwayYan-Jie Xu, Jie-Min Zhao, Cao Gao, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|March 21, 2007
[Multicenter phase II study of modified FOLFIRI regimen in the advanced colorectal cancer patient refractory to fluoropyrimidine and oxaliplatin]Wen Zhang, Zi-Yi Zhao, Qing Wu, et al.
World Journal of Gastroenterology|March 31, 2011
Paclitaxel based vs oxaliplatin based regimens for advanced gastric cancerXiao-Dong Li, Hua Shen, Jing-Ting Jiang, et al.
Pageof 5